skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
NONE
Issue Dt:
Application #:
16762286
Filing Dt:
05/07/2020
Publication #:
Pub Dt:
11/12/2020
Inventors:
Leeladhar SAMMATUR, Arthvan SHARMA, Genevieve WEIR, Andrea PENWELL et al
Title:
PHARMACEUTICAL COMPOSITIONS, METHODS FOR PREPARATION COMPRISING SIZING OF LIPID VESICLE PARTICLES, AND USES THEREOF
Assignment: 1
Reel/Frame:
052600/0427Recorded: 05/07/2020Pages: 7
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
01/09/2018
Exec Dt:
01/15/2018
Exec Dt:
01/10/2018
Exec Dt:
01/08/2018
Exec Dt:
01/12/2018
Exec Dt:
01/15/2018
Exec Dt:
01/08/2018
Assignee:
130 EILEEN STUBBS AVENUE
SUITE 19
DARTMOUTH, NOVA SCOTIA, CANADA B3B 2C4
Correspondent:
TROUTMAN SANDERS LLP
875 THIRD AVENUE
NEW YORK, NY 10022
Assignment: 2
Reel/Frame:
065241/0073Recorded: 10/16/2023Pages: 37
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
09/29/2023
Assignee:
312 FARMINGTON AVENUE
FARMINGTON, CONNECTICUT 06032
Correspondent:
ROPES & GRAY LLP
800 BOYLSTON STREET PRUDENTIAL TOWER
BOSTON, MA 02110
Assignment: 3
Reel/Frame:
066209/0905Recorded: 01/12/2024Pages: 37
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
09/29/2023
Assignee:
312 FARMINGTON AVENUE
FARMINGTON, CONNECTICUT 06032
Correspondent:
ROPES & GRAY LLP
800 BOYLSTON STREET PRUDENTIAL TOWER
BOSTON, MA 02110

Search Results as of: 06/22/2024 01:47 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT